StonvexLoading…
StonvexStonvexStonvexCore line items from IMRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $316.95K | $2.08M | $2.31M |
Operating Income | $-58.41M | $-51.74M | $-33.89M | $-17.08M |
Net Income | $-53.47M | $-50.51M | $-33.54M | $-17.04M |
EPS (Diluted) | $-1.88 | $-1.91 | $-2.46 | $-3.44 |
Total Assets | $102.58M | $122.37M | $166.70M | $38.42M |
Total Liabilities | $12.01M | $12.52M | $10.72M | $2.80M |
Cash & Equivalents | $59.41M | $72.64M | $74.89M | $37.09M |
Free Cash Flow OCF − CapEx | $-49.31M | $-44.84M | $-30.91M | $-14.67M |
Shares Outstanding | 28.42M | 26.39M | 13.61M | 4.95M |